Caffeine Research Today is a free monthly online journal that collates and summarizes the latest research about Caffeine, including details on addiction, drugs, effects, coffee.

Influences of caffeine, acetazolamide and cognitive stimulation on cerebral blood flow velocities.

Haase CG, Becka M, Kuhlmann J, Wensing G

Institute of Clinical Pharmacology, Pharma Research Center, Bayer HealthCare AG, D-42096 Wuppertal, Germany. haase.claus@kk-recklinghausen.de

Assessment of cerebral blood flow velocities (CBFV) can be used as a non-invasive tool to evaluate specific drug effects, like caffeine (CAF), acetazolamide (AA) as well as cognition. Their influences on each others CBFV were evaluated in detail, using a randomized, double-blind, double-dummy, placebo-controlled three-fold cross-over study design in 18 right-handed healthy male volunteers. CBFV (maximal, mean, minimal) and pulsatility index of both middle cerebral arteries were recorded by transcranial Doppler ultrasound simultaneously, during a verbal memory test, oral CAF, intravenous AA or placebo. AA led to increase in CBFV of 25-32%. Caffeine resulted in decreased V(mean) and V(min) of 10-13%. Cognitive stimulation resulted in a slight increase of CBVF of about 4%, but was overruled by effects of AA and CAF. We conclude that pharmacological effects can easily be assessed by TCD during clinical pharmacological studies of vasoactive drugs. However intraindividual variability and effects of neuropsychological stimulation needs to be taken into account.

Published 3 May 2005 in Prog Neuropsychopharmacol Biol Psychiatry, 29(4): 549-56.
Full-text of this article is available online (may require subscription).

© 2004-2008 Caffeine Research Today. All Rights Reserved.